Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Aging, widowhood, multiple sclerosis, and a dog.
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Value of NMO-IgG determination at the time of presentation as CIS.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Secukinumab: first global approval.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
A culture system to study oligodendrocyte myelination processes using engineered nanofibers.
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.

Pages